WO2000055579A2 - A system and method for detection and characterization of stenosis, blood vessels flow and vessel walls properties using vessel geometrical measurements - Google Patents
A system and method for detection and characterization of stenosis, blood vessels flow and vessel walls properties using vessel geometrical measurements Download PDFInfo
- Publication number
- WO2000055579A2 WO2000055579A2 PCT/IL2000/000172 IL0000172W WO0055579A2 WO 2000055579 A2 WO2000055579 A2 WO 2000055579A2 IL 0000172 W IL0000172 W IL 0000172W WO 0055579 A2 WO0055579 A2 WO 0055579A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- processor unit
- pressure
- operative
- wave velocity
- signal
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 63
- 208000031481 Pathologic Constriction Diseases 0.000 title claims abstract description 52
- 208000037804 stenosis Diseases 0.000 title claims abstract description 49
- 230000036262 stenosis Effects 0.000 title claims abstract description 49
- 210000004204 blood vessel Anatomy 0.000 title claims abstract description 23
- 238000005259 measurement Methods 0.000 title abstract description 30
- 238000001514 detection method Methods 0.000 title description 5
- 238000012512 characterization method Methods 0.000 title description 4
- 210000001367 artery Anatomy 0.000 claims abstract description 66
- 210000004369 blood Anatomy 0.000 claims abstract description 30
- 239000008280 blood Substances 0.000 claims abstract description 30
- 238000006073 displacement reaction Methods 0.000 claims abstract description 29
- 230000004807 localization Effects 0.000 claims abstract description 13
- 230000033001 locomotion Effects 0.000 claims description 22
- 238000002604 ultrasonography Methods 0.000 claims description 22
- 238000003825 pressing Methods 0.000 claims description 6
- 239000012530 fluid Substances 0.000 abstract description 17
- 238000004458 analytical method Methods 0.000 abstract description 7
- 230000005284 excitation Effects 0.000 abstract description 4
- 238000012360 testing method Methods 0.000 description 26
- 238000000338 in vitro Methods 0.000 description 17
- 238000002474 experimental method Methods 0.000 description 15
- 239000000523 sample Substances 0.000 description 15
- 239000004816 latex Substances 0.000 description 14
- 229920000126 latex Polymers 0.000 description 14
- 230000003902 lesion Effects 0.000 description 11
- 230000017531 blood circulation Effects 0.000 description 9
- 238000009530 blood pressure measurement Methods 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 230000000541 pulsatile effect Effects 0.000 description 8
- 230000007246 mechanism Effects 0.000 description 7
- 230000002792 vascular Effects 0.000 description 7
- 230000000747 cardiac effect Effects 0.000 description 6
- 230000010412 perfusion Effects 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 230000005355 Hall effect Effects 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 230000000737 periodic effect Effects 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 241000282414 Homo sapiens Species 0.000 description 3
- 239000004809 Teflon Substances 0.000 description 3
- 229920006362 Teflon® Polymers 0.000 description 3
- 238000002583 angiography Methods 0.000 description 3
- 238000002399 angioplasty Methods 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 230000014509 gene expression Effects 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- KKJUPNGICOCCDW-UHFFFAOYSA-N 7-N,N-Dimethylamino-1,2,3,4,5-pentathiocyclooctane Chemical compound CN(C)C1CSSSSSC1 KKJUPNGICOCCDW-UHFFFAOYSA-N 0.000 description 2
- 238000012404 In vitro experiment Methods 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000003143 atherosclerotic effect Effects 0.000 description 2
- 230000002308 calcification Effects 0.000 description 2
- 210000004351 coronary vessel Anatomy 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 230000035487 diastolic blood pressure Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002608 intravascular ultrasound Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 230000035488 systolic blood pressure Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 230000002537 thrombolytic effect Effects 0.000 description 2
- 206010002329 Aneurysm Diseases 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 244000261422 Lysimachia clethroides Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 101150118507 WASL gene Proteins 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 210000000709 aorta Anatomy 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 210000002302 brachial artery Anatomy 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 210000001168 carotid artery common Anatomy 0.000 description 1
- 239000002872 contrast media Substances 0.000 description 1
- 238000002586 coronary angiography Methods 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000003205 diastolic effect Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 239000013013 elastic material Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 230000007274 generation of a signal involved in cell-cell signaling Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 238000005534 hematocrit Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000013147 laser angioplasty Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 238000011369 optimal treatment Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 230000001902 propagating effect Effects 0.000 description 1
- 229910052761 rare earth metal Inorganic materials 0.000 description 1
- 150000002910 rare earth metals Chemical class 0.000 description 1
- 230000003134 recirculating effect Effects 0.000 description 1
- 238000001028 reflection method Methods 0.000 description 1
- 208000037803 restenosis Diseases 0.000 description 1
- 238000000518 rheometry Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 230000001732 thrombotic effect Effects 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/026—Measuring blood flow
- A61B5/0285—Measuring or recording phase velocity of blood waves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/021—Measuring pressure in heart or blood vessels
- A61B5/0215—Measuring pressure in heart or blood vessels by means inserted into the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/04—Measuring blood pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/48—Diagnostic techniques
- A61B8/485—Diagnostic techniques involving measuring strain or elastic properties
Definitions
- the present invention relates to the field of medical diagnostic and therapeutic devices for characterization of blood vessel lesions and properties using invasive and noninvasive measurements.
- Vascular diseases are often manifested by reduced blood flow due to atherosclerotic occlusion of vessels.
- occlusion of the coronary arteries supplying blood to the heart muscle is a major cause of heart disease.
- Invasive procedures for relieving arterial blockage such as bypass surgery and balloon dilatation with a catheter are currently performed relying on estimates of the occlusion characteristics and the blood flow through the occluded artery. These estimates are based on measurements of occlusion size and / or blood flow.
- current methods of occlusion size and blood flow measurement have low resolution, are inaccurate, are time consuming, require expertise in the interpretation of the results and are expensive.
- decisions on whether or not to use any of the blockage relieving methods and which of the methods should be used are often based on partial information. The evaluation of therapeutic success is also problematic, where both occlusion opening and stent position have to be evaluated.
- TCT transcatheter cardiovascular therapeutics
- CABG coronary artery bypass grafting
- Atherosclerotic lesions may have different characteristics. Some lesions exhibit a variable degree of calcification while others have a fatty or thrombotic nature. Lesion characteristics together with vessel condition proximal and distal to the lesion are the major factors for determining the therapeutic procedure needed.
- TCT starts with an interventional diagnosis procedure (angiography), followed by the treatment of the patient with medication therapy.
- CABG continuation of the TCT procedure with adequate interventional treatment.
- PTCA percutaneous transluminal angioplasty
- DC A directional coronary atherectomy
- RCA rotational coronary atherectomy
- TEC transluminal extraction catheter
- ELCA excimer laser angioplasty
- stents are placed within the lesion so as to prevent re-closure of the vessel (also known as recoil). If the stent is malpositioned, it interrupts the flow and may initiate restenosis.
- Lesion characteristics are used to determine the medically and economically optimal treatment method or combination of methods of choice.
- Angiography has been the main diagnostic tool in the catheter laboratory.
- the physician uses the angiographical images in order to identify and locate the lesions, evaluate the occlusion level (percentage of normal diameter) and qualitatively estimate the perfusion according to "thrombolysis in myocardial infarction" (TIMI) grades, determined according to the contrast material appearance.
- TIMI grades 0,1,2,3 represent no perfusion, minimal perfusion, partial perfusion and complete perfusion, respectively.
- QCA quantitative coronary angiography
- IVUS intravascular ultrasound
- IDVS intravascular Doppler velocity sensor
- IPS intravascular pressure sensor
- IVUS provides accurate geometrical data regarding cross section area and accurate information regarding the vessel wall structure and composition.
- IDVS provides velocity measurements, enabling discriminating various degrees of occlusion according to coronary flow reserve (CFR) criteria. IDVS suffers from inaccuracy problems resulting from positioning errors within the vessel.
- IPS provides pressure measurements enabling discriminating various degrees of occlusion according to the FFR (fractional flow reserve) criteria. Angiography and the sophisticated techniques discussed above may be employed prior to and after the therapeutic procedure (the last for the evaluation of the results and decision about correcting actions).
- the device is used for Noninvasive Examination of Input Vascular Impedance, elasticity of Arterial Walls and volumetric blood flow.
- Impedance is defined here as the ratio between blood pressure and blood flow in the linear approximation of blood flow.
- the apparatus is claimed to be a computerized Ultrasonic system consisting of a double ultrasonic probe locates at the same position along the artery. Both probes operate simultaneously, the first probe in the Echo-mode measures instantaneous vessel diameter and the second probe is in a CW-Doppler mode and measures blood flow (i.e., blood velocity). Being a single position probe, elasticity of the artery cannot be calculated by vessel diameter alone.
- the invention discloses a method and devices for determining volume flow, blood velocity profile, artery wall properties of a tubular conduit system and stenosis identification and localization by introducing an artificial pressure or flow excitation signal (a single signal or multiple signals) into the blood vessel (or in any other tubular flowing fluid conduits), and or using natural heart beat signals measurement and analysis of the vessel wall displacements or vessel diameter changes.
- an artificial pressure or flow excitation signal a single signal or multiple signals
- This invention provides an apparatus, and system for determining volume flow, blood velocity profile, and/or artery wall properties of a tubular conduit system and stenosis identification and localization, said apparatus comprising: a means for generating an artificial pressure signal or an artificial pressure wave velocity; a means for measuring artery diameter or displacement resulting from said artificial pressure signal or an artificial pressure wave velocity or using natural heart beat signals; a processor unit operatively connected to said measuring means; a program for controlling the processor unit, wherein said processor unit is operative with said program to receive said signal which is represented of the measure of said artery diameter or displacement resulting from said artificial pressure signal or an artificial pressure wave velocity or using natural heart beat signals and determine volume flow, blood velocity profile, and/or artery wall properties from analysis of the vessel wall displacements or vessel diameter changes.
- the processor unit is operative to select a method from a plurality of methods to generate artificial pressure signal or an artificial pressure wave velocity or using natural heart beat signals.
- the tubular conduit system is a blood vessel system and said processor unit is operative to detect changes in arterial characteristics.
- the processor unit is operative to determine volume flow.
- the processor unit is operative to detect stenosis.
- the processor unit is operative to determine blood velocity profile.
- the measuring means is by ultrasound or magnetic motion sensor. In another embodiment, the measuring means is by ultrasound. In another embodiment, the measuring means is by magnetic motion sensor. In another embodiment, the means for generating a pressure signal is in by a non-invasive means. In another embodiment, the means for generating a pressure signal is by an exciter. In another embodiment, the non-invasive means for generating a comprises a mechanical and/or electrical means. In another embodiment, the mechanical non-invasive means for generating a comprises applying pressure to the carotid.
- the signal is a plurality of discrete signals said processor unit is operative to sample said discrete signals and receive pressure wave velocity data. In another embodiment, the processor unit is operative to perform a single pressure function using said discrete signals and said pressure wave velocity data.
- This invention provides a method for determining volume flow, blood velocity profile, and/or artery wall properties of a tubular conduit system and stenosis localization, comprising: generating an artificial pressure signal or an artificial pressure wave velocity or using natural heart beat signals; and measuring artery diameter or displacement resulting from said artificial pressure signal or an artificial pressure wave velocity; thereby determining volume flow, blood velocity profile, and/or artery wall properties of a tubular conduit system.
- the processor unit is operative to select a method from a plurality of methods to generate artificial pressure signal or an artificial pressure wave velocity.
- the tubular conduit system is a blood vessel system and said processor unit is operative to detect changes in arterial characteristics.
- the processor unit is operative to determine volume flow.
- the processor unit is operative to detect stenosis.
- the processor unit is operative to determine blood velocity profile.
- the measuring means is by ultrasound or magnetic motion sensor. In another embodiment, the measuring means is by ultrasound. In another embodiment, the measuring means is by magnetic motion sensor. In another embodiment, the means for generating a pressure signal is in by a non-invasive means. In another embodiment, the means for generating a pressure signal is by an exciter. In another embodiment, the non-invasive means for generating a comprises a mechanical and/or electrical means. In another embodiment, the mechanical non-invasive means for generating a comprises applying pressure to the carotid.
- the signal is a plurality of discrete signals said processor unit is operative to sample said discrete signals and receive pressure wave velocity data. In another embodiment, the processor unit is operative to perform a single pressure function using said discrete signals and said pressure wave velocity data.
- This invention provides a method of determining the geometrical shape of the stenosis. Such determination as provided for herein is determined by comparing the pressure signal proximal to the stenosis to the pressure signal distal to the stenosis so as determine the geometrical shape of the stenosis. In another embodiment the reflection method as disclosed herein is determined and then based on the reflection the geometrical shape of the stenosis is determined.
- This invention provides a method and devices may also serve for evaluating the success of medical treatment. For example tracking sufficient opening for determining volume flow, blood velocity profile, and/or artery wall properties of a tubular conduit system occlusion or malpositioning of a stent. It may also serve for the characterization of vascular bed, downstream the vessel.
- the present invention provides a method for further analysis of the response to the excitation signal yielding a quantitative determination of elastic properties of blood vessel walls for characterizing, wter alia, the distensibility and the compliance of lesioned and non-lesioned parts of blood vessels.
- the derived elastic properties may be further used to determine the degree of calcification of lesioned and non-lesioned parts of blood vessels.
- Figure 1 illustrates an ultrasound measuring system for measuring vessel wall displacements or vessel diameter changes caused by heartbeats pressure signals.
- Figure 2 illustrates an ultrasound measuring system for measuring vessel wall displacements or vessel diameter changes caused by artificial pressure signals
- Figure 3 illustrates an exciter use for generating artificial pressure signal inside a blood vessel.
- Figure 4 illustrates an in vitro test apparatus used to verify the analytical results
- Figure 5 is a zoom on part of the in vitro test apparatus illustrated in Fig. 4.
- Figure 6 is a schematic description of the in vitro test apparatus.
- Figure 7 illustrates the Magnetic Motion Sensor incorporated within the in vitro test apparatus and used to measure tube wall displacements caused by pressure signal.
- Figure 8 illustrate the MMS together with the in vitro test apparatus.
- Figure 9 illustrates the test set up used in the experiment for flow determination.
- Figure 10 illustrates an in vitro test performed in order to determined the distensibility of the latex tube.
- Figure 1 1 illustrates the results of the in vitro test for determining the distensibility of the latex tube.
- Figure 12 illustrates test results of pressure measurements versus MMS output voltage.
- Figure 13 illustrates the pulses measured by the MMS in experiment for determining pressure wave velocity.
- Figure 14 is a graph illustrating comparison of the volume flow rate as a function of time as computed using model 2 and the flow as obtain from flow meter measurements.
- Figure 15 is a graph illustrating the tube wall shear stress as a function of time as calculated from data obtained from two experiments with different flow rate.
- Figure 16 illustrates flow axial velocity profile as calculated from the data obtained from an in vitro test.
- Figure 17 is a plot of computed axial centerline velocity using model 1.
- Figure 18 is a graph illustrating comparison of the volume flow rate as a function of time as computed using model 1 and the flow as obtain from flow meter measurements.
- Figure 19 illustrates comparison between the flow calculated from model 1 and 2for two different flow rates.
- Figure 20 illustrates a test setup for identifying and localizing stenosis.
- Figure 21 is a plot of the proximal and distal signal measured by the MMS in an in vitro test for identifying and localizing of a stenosis.
- Figure 22 is a zoom on the peaks of the pulses illustrated in Fig. 21.
- the present invention gives a method for deducing the volume flow rate, velocity profile, properties of artery walls (compliance and distensibility) and stenosis detection and localization.
- the method uses measurement of blood vessel cross section area (or diameter if the artery is quasi-circular) as a function of time.
- pressure and pressure wave velocity are derived from vessel area (or diameter) measurements enabling the determination of flow, wall properties and stenosis location.
- the method is designed to serve as a diagnostic tool for the physician when emphasis is put on optimizing measurement duration, computer resources and data processing time.
- knowing the area A(x,t), or diameter, D(x,t) is equivalent to knowing pressure.
- the pressure gradient when pressure is transversally constant
- the other is the pulsatile motion of the tube, which acts on the fluid through the no-slip condition enforcing zero fluid velocity (axial, radial and circumferential) at the wall.
- Flow, stenosis location and vessel wall properties are computed from geometrical measurements of blood vessel (wall displacement or artery diameter).
- Vessel diameter is measured using an ultrasound device or any other noninvasive device as for example described below. If an ultrasound apparatus is used, it must have a probe with at least two ultrasound lines at two different neighboring locations with known distance between them. The probe operates the two lines simultaneously in Echo-mode and measures vessel diameter. Pressure is derived from diameter measurements. The data is processed to yield two diameters which are functions of time.
- FIG. 1 illustrating the measuring system.
- An ultrasound-measuring device (1) is attached to a processor unit (3) and measures changes in blood vessel diameter (2) as a function of time. The changes in diameter are due to pressure pulses caused by heartbeats. Measurements are performed at two neighboring points. A stenosis (4) might be present, distally, in which case it will be detected. From these geometrical measured data, flow, stenosis location (if present) and artery wall properties are computed.
- the displacements of artery walls may be determined using more than two measuring points along the artery. In such a case P(x,t) is derived from the multi number of measurements.
- the displacements of artery walls may be determined using ultrasound measurement of a single artery section. In such case, a second measurement of another section, located at a known distant from first section is performed later. Then time synchronization of the measured results has to be performed.
- the displacements of artery walls may be determined using Magnetic Motion Sensor (MMS) which measures the vessel wall displacements.
- MMS Magnetic Motion Sensor
- Such a device capable of measuring wall displacements of latex tube is incorporated within an in vitro test system.
- the laboratory MMS device is illustrated in Figs 7 and 8.
- a device, based on the same principles, may be adjusted for clinical purposes and used for measuring vessel wall displacements. This is possible in cases of arteries located close enough to the body external skin, such as the carotid.
- an exciter (a short duration pulses generator) may be used.
- the exciter (5) generates an artificial pressure pulse that propagates along the vessel.
- the pressure pulse is introduced into the vessel by a catheter (6).
- the changes in vessel diameter (2) caused by the excited pressure signal going forward and the reflected signal coming backward from a stenosis (4) are measured by an ultrasound device (1).
- the changes in diameter are better detected and measured than those caused by heartbeats. This improves the accuracy of measurements and results.
- the exciter is a device for the excitation of the pressure waves inside the tube (catheter). It consists of a hammer (7) and conical chamber (8). Low voltage is applied to the solenoid (not shown) that pushes the weight (hammer). This weight strikes the membrane (9) of the conical chamber thus initiating a short pressure pulse.
- the opening of the cone is connected to a catheter (6). In the initial state the chamber and the catheter are filled with the fluid. The movement of the membrane is allowed only in one direction, so only positive pressure pulse is produced. The membrane returns to its initial position by the effect of a spring. Displacement of the membrane and pressure wave generation could be achieved as well by using an actuator based on piezoelement or other pressure generating device.
- the methods provided herein are based on introducing an artificial pressure signal into the blood vessel.
- the pressure signal originates from a pressure signal generator (PSG).
- PSG pressure signal generator
- a PSG of the type suitable for this purpose is a "blood pressure systems calibrator” model 601 A, commercially available from Bio-Tek Instruments Inc., Highland Park, Box 998, Winooski, VT-05404-0998, U.S.A.
- Catheterization laboratory injection systems are known to those skilled in the art.
- a system of the type suitable for this purpose is a "Mark V Plus Injection System" from Medrad, inc. 271 Kappa Drive, Pittsburgh,PA 15238-2870 U.S.A.
- a pressure signal generated within the catheter or in its distal tip e.g. piezoelectrically or by another form of energy burst introduction e.g. AcolysisSystem, ultrasound thrombolysis selective lysis of fibrin, by Angiosonics Inc., NC, U.S.A.
- a pressure signal generated within the catheter or in its distal tip is by the movement of an hydrodynamic surface, activated either manually or by a special mechanism (e.g catheter used for removing malpositioned or embolized stents, for example Amplatz Goose Neck Snare GN 500 and Microsnare SK200 from Microvena corporation, Minnesota USA and catheters which prevent plaque debris from moving downstream);
- a pressure signal caused by an external controlled pressure applied on an organ transmitted into a pressure signal within the vessel;
- a pressure signal caused by a non-invasive energy transmission into the vessel e.g. ultrasound in which the artificial pressure/flow signal may be either controlled or measured (within the catheter or the vessel).
- the methods provided herein are based on using natural heart beat signals measurement and analysis of the vessel wall displacements or vessel diameter changes.
- the signal generator is a pressure signal generator; said signal sensor is a pressure signal sensor; and said processor unit is operative to receive a heart beat signal; and synchronize receipt of said probe signal with said heart beat signal.
- the signal sensor includes at least two sensing transducers disposed in spaced apart relation. The signal sensor is movable between at least two positions relative to said tubular conduit system and said processor unit is operative to calculate a pressure wave velocity from signals received from said two positions.
- the signal sensor includes a signal conditioner. The signal may be derived from either one of the internally generated waveforms or excited electronically from a separate signal generator either a stand alone unit.
- a stand alone unit is of the type suitable is a multifunction synthesizer model HP8904A from HP Test and measurement Organization, a Hewlett Packard company USA) or integrated within a system computer, otherwise used for data acquisition and analysis.
- HP8904A from HP Test and measurement Organization, a Hewlett Packard company USA
- an electric impulse generator is shown in Figure 29.
- the pressure signal may originate from an impact mechanism system.
- impact mechanisms are known to those skilled in the art.
- the impact mechanisms may be of the spring loaded or electronically activated mechanical impact system types, applying pressure on either the catheter or on a container attached to it.
- a signal generation apparatus (in vitro and in vivo) of the impact mechanism type makes use of a pistol hammer mechanism, where the pistol hammer hits directly on the catheter, lying on a rigid surface.
- the pistol used was a P230 semiautomatic pistol from Sig Sauer, Switzwerland.
- the same pistol hammer hit the head of a standard 5 ml syringe, where the syringe was connected to the catheter through a standard manifold.
- the artificial pressure flow signal may also be synchronized with heart beats, either by gating to ECG or to system measurements (pressure or flow) in which the ECG device measures heart heat signals upon reaching a desired time in the heart beat triggering the artificial pressure flow signal.
- the pressure signal advances through a catheter lumen into the blood vessel.
- the catheter may be a guiding catheter.
- a guiding catheter of the type suitable for this purpose is a 8F Archer coronary guiding catheter from Medtronic Interventional Vascular, Minneapolis, U.S.A.
- a diagnostic catheter of the type suitable for this purpose is a Siteseer diagnostic catheter, from Bard Cardiology. U.S.A.
- a balloon catheter of the type suitable for this purpose is a Supreme fasr exchange PTCA catheter, by Biotronik GMBH & Co, U.S.A. It should be noted that almost any type of hollow catheter may be used.
- the presence of occlusion or aneurysm downstream creates reflection of pressure and flow waves. By extracting data of the reflected pressure waves, originated in the occluded site, the location and degree of occlusion can be determined using signal processing methods.
- the performance of pressure wave velocity and reflection site parameters (position and reflection coefficient) estimation is based on two-point pressure measurement carried out inside of an artery.
- the pressure is measured either simultaneously by two pressure sensors or in different time by single sensor with some additional synchronization mechanism. In the case of the simultaneously pressure measurement two pressure sensors are placed throw known distance d. In the single sensor case the pressure is firstly measured in point a (upstream) and after that - in point b (downstream).
- Compliance and distensibility are related to Pressure Wave Velocity as follows:
- the pressure velocity c is related to the measured Pressure wave velocity (PWV) through:
- Ao is the area corresponding to an internal reference pressure Po.
- Human arteries are stiffer at higher pressure.
- Several empirical models have been proposed and may be used for more accurate results.
- ho and Do are the wall thickness and arterial diameter at reference pressure Po, respectively and E is the effective elastic modulus.
- E is the effective elastic modulus.
- a popular model is the one of Langewouters et al., (1984) using an arctangent function and three optimal fit parameters:
- Model 1 Transversally averaged Fluid Dynamics Equations:
- This model is a quasi-linear model in which the fluid dynamical equations are integrated over the cross section. It is especially useful for arteries in which the cross-section is manifestly non-circular. In effect it transforms the full three dimensional flow equation to one-dimensional ones in the couple Q and P where Q(x,t) is the volume flow rate or alternatively A and Q since A and P are related through compliance.
- Q(x,t) is the volume flow rate or alternatively A and Q since A and P are related through compliance.
- the price of such a drastic simplification is the introduction of empirical constants. Fortunately, these constants have a small effect so that they need not be known with great accuracy.
- the basic equations are the continuity and momentum equations (Navier-Stokes). It is convenient to use cylindrical coordinate where x is the axial coordinate along the tube, r is the radial coordinate and ⁇ is the circumferential angle.
- the parameter ⁇ varies between 1 for a blunt velocity profile and 4/3 for a parabolic velocity profile. In arteries it is observed that ⁇ is very close to one. In addition, the quadratic term is very small, except possibly at severe constrictions (stenoses).
- the integral on the r.h.s. represents the force exerted by the wall on the fluid.
- the wall shear stress (WSS) conventionally denoted by ⁇ having dimensions of a pressure is defined as:
- Eqs (17) and (22) are the one-dimensional equations for A and Q in the long-wave-length approximation.
- quadratic term in Q and the stress one recovers the well-known linear model. It remains to find an appropriate model for the WSS as well as ?.
- the pressure drop in a pulsatile flow is mainly due to both viscous effects and to a pressure force for flow acceleration.
- the PoiseuiUe WSS for a steady flow is 8 ⁇ proportional to - Q whereas the inertial force is proportional to the time derivative pA of Q.
- the coefficients c u and c v are slowly varying coefficients depending on the Womersley number: ⁇ p a R (24) ⁇
- the first term in the stress expression is the usual PoiseuiUe stress and the second one is an unsteady contribution.
- aorta c » 1.1 and c u » 1.6.
- a computational and clinical study should yield an optimal set of coefficients.
- Compliance and distensibility are explicit functions of x.
- the initial value of A as well as Q must be specified (i.e. A(x,0) and Q(x,0) for all x in the segment [0,L] ).
- the difficulty resides in the absence of datum concerning the initial flow.
- the initial conditions rapidly die off.
- the system of equations is run with arbitrary initial conditions (e.g., zero flow) with repeating the datum for a few periods (up to ten periods, typically) until the system settles in the periodic regime.
- Model 2 relates to a generalized case where the artery is with or without tapering.
- the case of no tapering is a simplified case of model 2.
- V x (r,x,t) f 0 (r,t)+xf x (r,t) (38a) dP(z, t)
- the boundary conditions are along the centerline
- the minimal areas at the N x positions are recorded by selecting the minimal area in time at each of those positions.
- Pressure signals are computed according to the compliance model. For example: from the formula in the constant distensibility mode one obtains the N x signals:
- N x values of (x, , t, ) are constructed through the N ⁇ positions points on the measured segment. This is necessary for solving the numerical equations by finite differences or finite elements. For example, in the case of two measuring points x and Xi+L Pix ⁇ -Pi ⁇ +JL ⁇ t j )
- the pressure gradient is dP ( - + x 3 )P(x, , t ) (x, + x 3 )R(x 2 , t ) (x, + x 2 )R(x 3 , t )
- the non invasive sensors measure diameters and upon using the Pressure- Area (or diameter) relation the pressure signal are obtained.
- the pressure wave can be linearly decomposed into a forward moving and backward moving wave, P f (x,t) and P b (x,t) , respectively.
- the pressure wave is a sum of a forward and backward moving wave:
- the backward wave originates from reflection of the forward wave at the stenosis and in the linear approximation the forward wave of angular frequency ⁇ yields a reflected wave of the same frequency multiplied by a (complex) reflection coefficient R( ⁇ ) so that :
- proximal and distal sensors have coordinate "0" and "Z", respectively.
- the backward wave at a given sensor is equal to R times the path from the sensor to the stenosis and back; the path equals 2L for the proximal sensor and (2L-Z) for the distal sensor.
- F( ⁇ ) and G( ⁇ ) denote the Fourier transforms of P(0,t) and P(Z,t), respectively. They are equal to the expressions multiplying exp(-j ⁇ t) under the integral sign. Upon dividing F( ⁇ ) by G( ⁇ ) it follows that:
- the ratio of the Fourier transforms of the proximal and distal pressure pulses is a known function of ⁇ , R, L and Z and CC( ⁇ ).
- Z the distance between probes is known.
- the PWV can be computed using the method described here in above. There remain, three parameters R, L (the distance to the stenosis) and the attenuation coefficient, ⁇ . To be computed. In practice, a least-square fit procedure is the easiest method, as shown next (the left and right hand side of Eq.(62) are denoted, rat( ⁇ ) and t( ⁇ ), respectively). Then R, L and ⁇ are given by:
- the integral is minimum at the physical values of R, L and ⁇ (the integral is taken over a frequency interval such that the proximal and distal power spectra are, say, at least 20 times larger than the power spectrum of the noise).
- the reflection coefficient may be considered as a real number independent of frequency [Stergiopulos et all 996).
- the main clinical application of the method is in detecting downstream stenosis which would otherwise be hidden from the other modalities.
- the internal carotid is situated behind the jaw and thus opaque to B-mode ultrasound.
- the wall of an artery closest to the skin is called the anterior wall, while the side farthest from the skin is the posterior wall. It has been observed that the anterior wall of a carotid undergoes a greater displacement than the posterior wall during a cardiac cycle (Reneman, Hoeks and Westerhof 1996). The same phenomenon might be observed in other peripheral arteries as well.
- the PWV can be measured by measuring the time between arrival of the peaks of ⁇ ant(t,xj) and ⁇ ant(t,x 2 ) measured at times ti and t 2 , respectively.
- the PWV, c is then given by:
- FIG. 4, 5and 6 4 illustrating an in-vitro experimental apparatus constructed and operative for determining flow characteristics in simulated non lesioned and lesioned blood vessels,.
- the fluidics system 51 of Fig. 4 is a recirculating system for providing pulsatile flow.
- the system 51 includes a pulsatile pump 42 model 1421 A pulsatile blood pump, commercially available from Harvard Apparatus, Inc., Ma, U.S.A., however other suitable pulsatile pumps can be used.
- the pump 42 allows control over rate, stroke volume and systole/diastole ratio.
- the pump 42 re-circulates glycerin solution from a reservoir 15 to a reservoir 14.
- the system 51 further includes a flexible tube 43 immersed in a water bath 44, to compensate for gravitational effects.
- the flexible tube 43 is made from Latex and has a length of 120 cm.
- the flexible tube 43 simulates an artery.
- the flexible tube 43 is connected to the pulsatile pump 42 and to other system components by Teflon tubes. All the tubes in system 51 have 4 mm internal diameter.
- a bypass tube 45 allows flow control in the system and simulates flow partition between blood vessels.
- a Windkessel compliance chamber 46 is located proximal to the flexible tube 43 to control the pressure signal characteristics.
- a Windkessel compliance chamber 47 and a flow control valve 48 are located distal to flexible tube 43 to simulate the impedance of the vascular bed.
- the system also includes a flowmeter 1 1 connected distal to the flexible tube 43 and a flowmeter 12 connected to the bypass tube 45.
- the flown meters 11 and 12 are suitably connected to A/D converter (not shown).
- the flow meters 1 1 and 12 are model 111 turbine flow meters, commercially available from McMillan Company, TX, U.S.A.. In certain cases, an ultrasonic flow meter model T206, commercially available from Transonic Systems Inc., NY, U.S.A is used.
- An exciter (5) is connected to the flexible tube (43) through a catheter (6) enable introducing pressure pulses inside the tube.
- Fig. 5 is a schematic cross sectional view illustrating a part of the fluidics system 51 in detail.
- An artificial stenosis made of a tube section 55, inserted within the flexible tube 43 is described.
- the tube section 55 is made from a piece of Teflon tubing.
- the internal diameter of the artificial stenosis 55 may be varied by using artificial stenosis sections fabricated separately and having various internal diameter.
- the system 41 includes the system 51.
- the system 41 also includes a signal conditioner 23 model TCB-500 control unit commercially available from Millar Instruments.
- Data acquisition was performed using a PC - Pentium 586 (20 with an E series Instruments multifunction I/O board model PC-MIO-16E-4, commercially available from National Inc., TX, U.S.A.
- the I/O board was controlled by a Labview graphical programming software, commercially available from National Instruments Inc., TX, U.S.A. 10 sec interval of pressure and flow data were sampled at 5000Hz, displayed during the experiments on the monitor and stored on hard disk. Analysis was performed offline using Matlab version 5 software, commercially available from The Math Works, Inc., MA, U.S.A.
- Figs. 7 and 8 illustrating the magnetic motion sensor (MMS) device attached to the in vitro test system 51.
- MMS magnetic motion sensor
- the sensor array measures small changes in diameter along a latex tube while the tube inner diameter is under water pressure variation caused by a pump simulating a human heart. Tests show that the sensors are able to sense movements as small as a few microns in real time and that these movements correspond well to pressure measurements obtained simultaneously using a Radi pressure sensor inside the tubing. In order to minimize the effects of the sensor array on the latex tube Hall Effect sensors were arranged to measure movements of small magnets cemented to the surface of the latex tubing.
- a total of six Hall Effect sensors are spaced at 2 CM intervals along the latex tubing and several MM above the tubing.
- Small rare earth magnets are placed above and below the sensors with there like magnetic poles facing each other. This arrangement creates a magnetic field that is almost linear near the center point between the magnets.
- the top magnet is fixed relative to the Hall effect sensor, while the lower magnet is free to move with the changing diameter of the tubing.
- the opposite side of the tubing diameter is fixed to 2 MM diameter posts opposite each sensing position.
- Each Hall Effect sensor generates an output voltage proportional to the change in magnetic field strength that is in turn proportional to the change in tubing diameter.
- the sensor voltage is amplified by a low noise instrumentation amplifier followed by a differential output line driver which is drives a set of cables to the nearby data acquisition system.
- the experiment was performed using the in vitro test apparatus illustrated in Figs. 4,5,6 using a flexible tube under the action of an external pulsating pump simulating heart beat.
- the test configuration is illustrated in Fig. 9.
- the pump is a pulsating HarvardTM pump producing pressure pulses simulating heartbeats.
- the flexible tube is made of latex simulates blood vessel wall characteristics of 70 years old man.
- the latex tube is filled by fluid consists of a 60 % water and 40 % glycerine mixture with a density of 1103 Kg/m and a measured viscosity close to the one measured in blood.
- the data was acquired at a sampling rate equal to 5000 Hz and digitized using an A/D board.
- the data acquisition was monitored with a LABVIEWTM program and then processed through a MatlabTM program (FID), (the sampling rate is much higher than needed for computations)
- the MMS system output is voltage signal that follows the tube diameter changes caused by pressure variation in the vessel produced by the pump.
- the voltage signal is translated into pressure units by means of sensor calibration.
- For the pu ⁇ ose of calibration we use a single pressure sensor MillarTM in a static configuration. The sensor characteristic obtained was practically linear. Distensibility of the latex tube:
- a pressure sensor 21 (Millar) is positioned in the experimental setup without pump. The pressure sensor is calibrated to zero pressure at atmospheric pressure. Both ends of the tube are closed whereas at one end a syringe is attached to the tube. The length of the tube is 1.31 m and the diameter of the tube filled with fluid at atmospheric pressure is 3.6 mm. The volume of the tube, Vo, (neglecting the Y-connectors) is 13.34 ml. The Syringe capacity is 2.4 ml. Small quantities of fluids are injected into the tube and the pressure read by the Millar sensor is plotted as a function of the logarithm of the volume in the tube, V 0 + ⁇ V. If the latex tube exhibits constant distensibility the following holds
- Po' The value of Po' is the pressure at zero flow.
- MMS Voltage as a function of time.
- Several methods may be used. Basically the method computes the shift in time between arrivals of the pulses at the magnetic sensors. Due to imperfections in the systems such as tube instabilities, pump variations and other factors, there is a spread in the PWV values. A train of 44 pulses was selected and outliers eliminated (less than 8 m s and more than 20 m/s).
- Fig. 16 illustrating a plot of the axial velocity profile for a single period with volume flow rate 120 ml/min. It is convenient to measure time by an angular variable, a whole period being 360 degrees. Velocity profiles as function of time for volume flow rate 120 ml/min
- the maximum (or peak) velocity is seen to be situated along the centerline of the tube.
- Doppler velocity was measured using a 0.0014 inch Doppler guide wire (FlowireTM, Cardiometrics, Inc., Mountain View CA).
- a proprietary real-time fast Fourier analyzer (FlowmapTM Cardiometrics, Inc.) with automated tracking of the maximal velocity of the Doppler spectrum was employed to measure peak Doppler velocity.
- the Doppler shift reflected by red cells is recorded (we use corn-flour starch, instead).
- Fig. 17 illustrating a plot of the calculated centerline axial velocity using Model 1 (continuous curve) and the peak velocity as measured by the Flow ire.
- the volume flow rate is 120 ml/min. Results using Model 1 :
- Model 1 The computed volume flow rate using model 1 is plotted in Fig. 18 together with the output of the Flow-Meter.
- the results are quite insensitive to small changes in these parameters.
- Model 1 is more limited than Model 2, since its only output is volume flow rate. In the present situation were the tube is circular and there is no swirl, it is not advantageous to use Model 1.
- Model 1 and Model 2 Reference is now made to Fig. 19 The volume flow rates given by Model 1 and Model 2 are compared and are almost identical.
- Fig. 21 is a plot of the proximal and distal signal measured by the MMS.
- the stenosis has a diameter of 1 mm and a length of 1 cm and is located at a distance of 16 cm from the proximal magnet.
- Fig 22 is a zoom about the peaks of the pulses illustrated in Fig. 21.
- “A” and “B are the pulses measured by proximal and distal magnet, respectively.
- test data (Teflon tube diameter) was measured using the MMS which used as a demonstration device. By using Medical Ultrasound systems or other well-developed systems the result will be more accurate.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Physiology (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Medical Informatics (AREA)
- Physics & Mathematics (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
Abstract
Description
Claims
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2000233210A AU2000233210A1 (en) | 1999-03-16 | 2000-03-16 | A system and method for detection and characterization of stenosis, blood vessels flow and vessel walls properties using vessel geometrical measurements |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12456799P | 1999-03-16 | 1999-03-16 | |
US60/124,567 | 1999-03-16 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000055579A2 true WO2000055579A2 (en) | 2000-09-21 |
WO2000055579A3 WO2000055579A3 (en) | 2001-01-11 |
Family
ID=22415619
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IL2000/000172 WO2000055579A2 (en) | 1999-03-16 | 2000-03-16 | A system and method for detection and characterization of stenosis, blood vessels flow and vessel walls properties using vessel geometrical measurements |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2000233210A1 (en) |
WO (1) | WO2000055579A2 (en) |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1317902A1 (en) * | 2001-12-10 | 2003-06-11 | Kabushiki Gaisha K-and-S | Biological data observation apparatus |
WO2017198871A1 (en) | 2016-05-20 | 2017-11-23 | Koninklijke Philips N.V. | Determining pulse wave velocity using intravascular pressure measurement and external ultrasound imaging, and associated devices, systems, and methods |
CN108051141A (en) * | 2017-12-29 | 2018-05-18 | 四川大学华西医院 | Pressure-adjustable ultrasonic imitation body |
CN110198657A (en) * | 2016-12-01 | 2019-09-03 | 爱德华兹生命科学公司 | Aortostenosis classification |
US10736593B2 (en) | 2012-09-25 | 2020-08-11 | Canon Medical Systems Corporation | X-ray diagnostic apparatus and medical image processing apparatus |
US10806428B2 (en) | 2015-02-12 | 2020-10-20 | Foundry Innovation & Research 1, Ltd. | Implantable devices and related methods for heart failure monitoring |
US10806352B2 (en) | 2016-11-29 | 2020-10-20 | Foundry Innovation & Research 1, Ltd. | Wireless vascular monitoring implants |
US11039813B2 (en) | 2015-08-03 | 2021-06-22 | Foundry Innovation & Research 1, Ltd. | Devices and methods for measurement of Vena Cava dimensions, pressure and oxygen saturation |
US11206992B2 (en) | 2016-08-11 | 2021-12-28 | Foundry Innovation & Research 1, Ltd. | Wireless resonant circuit and variable inductance vascular monitoring implants and anchoring structures therefore |
US11564596B2 (en) | 2016-08-11 | 2023-01-31 | Foundry Innovation & Research 1, Ltd. | Systems and methods for patient fluid management |
US11701018B2 (en) | 2016-08-11 | 2023-07-18 | Foundry Innovation & Research 1, Ltd. | Wireless resonant circuit and variable inductance vascular monitoring implants and anchoring structures therefore |
US11779238B2 (en) | 2017-05-31 | 2023-10-10 | Foundry Innovation & Research 1, Ltd. | Implantable sensors for vascular monitoring |
USD1018557S1 (en) | 2019-05-17 | 2024-03-19 | Opsens, Inc. | Display screen or portion thereof with graphical user interface |
US11944495B2 (en) | 2017-05-31 | 2024-04-02 | Foundry Innovation & Research 1, Ltd. | Implantable ultrasonic vascular sensor |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4586514A (en) * | 1983-08-10 | 1986-05-06 | Biotronics Instruments | Phonoangiographic spectral analysing apparatus |
WO1992022239A1 (en) * | 1991-06-12 | 1992-12-23 | Florida Atlantic University Research Corp. | Detecting atherosclerosis in humans |
US5409010A (en) * | 1992-05-19 | 1995-04-25 | Board Of Regents Of The University Of Washington | Vector doppler medical devices for blood velocity studies |
US5429136A (en) * | 1993-04-21 | 1995-07-04 | Devices For Vascular Intervention, Inc. | Imaging atherectomy apparatus |
GB9318932D0 (en) * | 1993-09-14 | 1993-10-27 | Horrocks Michael | Vascular investigation |
-
2000
- 2000-03-16 AU AU2000233210A patent/AU2000233210A1/en not_active Abandoned
- 2000-03-16 WO PCT/IL2000/000172 patent/WO2000055579A2/en active Application Filing
Cited By (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6953435B2 (en) | 2001-12-10 | 2005-10-11 | Kabushiki Gaisha K -And- S | Biological data observation apparatus |
EP1317902A1 (en) * | 2001-12-10 | 2003-06-11 | Kabushiki Gaisha K-and-S | Biological data observation apparatus |
US10736593B2 (en) | 2012-09-25 | 2020-08-11 | Canon Medical Systems Corporation | X-ray diagnostic apparatus and medical image processing apparatus |
US10806428B2 (en) | 2015-02-12 | 2020-10-20 | Foundry Innovation & Research 1, Ltd. | Implantable devices and related methods for heart failure monitoring |
US10905393B2 (en) | 2015-02-12 | 2021-02-02 | Foundry Innovation & Research 1, Ltd. | Implantable devices and related methods for heart failure monitoring |
US11039813B2 (en) | 2015-08-03 | 2021-06-22 | Foundry Innovation & Research 1, Ltd. | Devices and methods for measurement of Vena Cava dimensions, pressure and oxygen saturation |
WO2017198871A1 (en) | 2016-05-20 | 2017-11-23 | Koninklijke Philips N.V. | Determining pulse wave velocity using intravascular pressure measurement and external ultrasound imaging, and associated devices, systems, and methods |
CN109152541A (en) * | 2016-05-20 | 2019-01-04 | 皇家飞利浦有限公司 | Pulse wave velocity and associated equipment, system and method are determined using the measurement of arteries and veins overpressure and external ultrasound imaging |
JP2019518518A (en) * | 2016-05-20 | 2019-07-04 | コーニンクレッカ フィリップス エヌ ヴェKoninklijke Philips N.V. | Associated devices, systems, and methods for determining pulse wave velocity using intravascular pressure measurement and external ultrasound imaging |
US11701018B2 (en) | 2016-08-11 | 2023-07-18 | Foundry Innovation & Research 1, Ltd. | Wireless resonant circuit and variable inductance vascular monitoring implants and anchoring structures therefore |
US11206992B2 (en) | 2016-08-11 | 2021-12-28 | Foundry Innovation & Research 1, Ltd. | Wireless resonant circuit and variable inductance vascular monitoring implants and anchoring structures therefore |
US11564596B2 (en) | 2016-08-11 | 2023-01-31 | Foundry Innovation & Research 1, Ltd. | Systems and methods for patient fluid management |
US12268493B2 (en) | 2016-08-11 | 2025-04-08 | Foundry Innovation & Research 1, Ltd. | Systems and methods for self-directed patient fluid management |
US12310707B2 (en) | 2016-08-11 | 2025-05-27 | Foundry Innovation & Research 1, Ltd. | Wireless resonant circuit and variable inductance vascular monitoring implants and anchoring structures therefore |
US10806352B2 (en) | 2016-11-29 | 2020-10-20 | Foundry Innovation & Research 1, Ltd. | Wireless vascular monitoring implants |
EP3547904A4 (en) * | 2016-12-01 | 2019-11-20 | Edwards Lifesciences Corporation | Aortic stenosis classification |
CN110198657A (en) * | 2016-12-01 | 2019-09-03 | 爱德华兹生命科学公司 | Aortostenosis classification |
US11779238B2 (en) | 2017-05-31 | 2023-10-10 | Foundry Innovation & Research 1, Ltd. | Implantable sensors for vascular monitoring |
US11944495B2 (en) | 2017-05-31 | 2024-04-02 | Foundry Innovation & Research 1, Ltd. | Implantable ultrasonic vascular sensor |
CN108051141A (en) * | 2017-12-29 | 2018-05-18 | 四川大学华西医院 | Pressure-adjustable ultrasonic imitation body |
USD1018557S1 (en) | 2019-05-17 | 2024-03-19 | Opsens, Inc. | Display screen or portion thereof with graphical user interface |
Also Published As
Publication number | Publication date |
---|---|
AU2000233210A1 (en) | 2000-10-04 |
WO2000055579A3 (en) | 2001-01-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6354999B1 (en) | System and method for detecting, localizing, and characterizing occlusions and aneurysms in a vessel | |
US6193669B1 (en) | System and method for detecting, localizing, and characterizing occlusions, stent positioning, dissections and aneurysms in a vessel | |
US6471656B1 (en) | Method and system for pressure based measurements of CFR and additional clinical hemodynamic parameters | |
WO1999034724A2 (en) | Characterizing blood vessel using multi-point pressure measurements | |
EP1251769A1 (en) | A method and system for pressure based measurements of cfr and additional clinical hemodynamic parameters | |
WO2001013779A2 (en) | A method and system for stenosis identification, localization and characterization using pressure measurements | |
WO2000055579A2 (en) | A system and method for detection and characterization of stenosis, blood vessels flow and vessel walls properties using vessel geometrical measurements | |
WO2001021057A2 (en) | A method and system for determination of ffr based on flow rate measurements | |
JPH11513276A (en) | Detection of vascular stenosis in chronic hemodialysis patients | |
Kinney et al. | Intraarterial pressure measurements during angiographic evaluation of peripheral vascular disease: techniques, interpretation, applications, and limitations. | |
Olesen et al. | Noninvasive estimation of pressure changes using 2-D vector velocity ultrasound: an experimental study with in vivo examples | |
EP3922173A1 (en) | Systems and methods for obtaining a pulse wave velocity measurement | |
US20040088123A1 (en) | Method for real-time monitoring of cardiac output and blood flow in arteries and apparatus for implementing the same | |
JPWO2006043528A1 (en) | Ultrasonic diagnostic apparatus and control method of ultrasonic diagnostic apparatus | |
EP1079727A1 (en) | Apparatus and method for identification and characterization of lesions and therapeutic success by flow disturbances analysis | |
Urchuk et al. | 1995 SMR young investigators' award finalist: MR measurement of time‐dependent blood pressure variations | |
Ashtekar et al. | In vitro quantification of guidewire flow-obstruction effect in model coronary stenoses for interventional diagnostic procedure | |
EP3831307A1 (en) | An apparatus for determining a physiological parameter relating to a vessel | |
JP2008161546A (en) | Ultrasonic diagnostic equipment | |
JP5014132B2 (en) | Ultrasonic diagnostic equipment | |
Jenni et al. | In vitro validation of volumetric blood flow measurement using Doppler flow wire | |
Beard et al. | A Doppler flowmeter for use in theatre | |
Weber et al. | Validation of Doppler measurement of pressure gradients across peripheral model arterial stenosis | |
Hutchison et al. | Stability of flow patterns in the in vivo post-stenotic velocity field | |
CN109350124A (en) | The continuous pressure measuring system of minimally-invasive blood vessel based on ultrasonic transducer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WPC | Withdrawal of priority claims after completion of the technical preparations for international publication | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |